Thalidomide is an inhibitor of angiogenesis
- PMID: 7513432
- PMCID: PMC43727
- DOI: 10.1073/pnas.91.9.4082
Thalidomide is an inhibitor of angiogenesis
Abstract
Thalidomide is a potent teratogen causing dysmelia (stunted limb growth) in humans. We have demonstrated that orally administered thalidomide is an inhibitor of angiogenesis induced by basic fibroblast growth factor in a rabbit cornea micropocket assay. Experiments including the analysis of thalidomide analogs revealed that the antiangiogenic activity correlated with the teratogenicity but not with the sedative or the mild immunosuppressive properties of thalidomide. Electron microscopic examination of the corneal neovascularization of thalidomide-treated rabbits revealed specific ultrastructural changes similar to those seen in the deformed limb bud vasculature of thalidomide-treated embryos. These experiments shed light on the mechanism of thalidomide's teratogenicity and hold promise for the potential use of thalidomide as an orally administered drug for the treatment of many diverse diseases dependent on angiogenesis.
Similar articles
-
Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization.Exp Eye Res. 1997 Jun;64(6):971-8. doi: 10.1006/exer.1997.0292. Exp Eye Res. 1997. PMID: 9301478
-
Thalidomide and a thalidomide analogue inhibit endothelial cell proliferation in vitro.J Neurooncol. 1999 Jun;43(2):109-14. doi: 10.1023/a:1006202700039. J Neurooncol. 1999. PMID: 10533722
-
Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits.Br J Cancer. 1999 Jan;79(1):114-8. doi: 10.1038/sj.bjc.6690020. Br J Cancer. 1999. PMID: 10408702 Free PMC article.
-
Deciphering the mystery of thalidomide teratogenicity.Congenit Anom (Kyoto). 2012 Mar;52(1):1-7. doi: 10.1111/j.1741-4520.2011.00351.x. Congenit Anom (Kyoto). 2012. PMID: 22348778 Review.
-
Thalidomide-a notorious sedative to a wonder anticancer drug.Curr Med Chem. 2013;20(33):4102-8. doi: 10.2174/09298673113209990198. Curr Med Chem. 2013. PMID: 23931282 Free PMC article. Review.
Cited by
-
Possible New Candidates Involved to Thalidomide-Related Limbs and Cardiac Defects: A Systems Biology Approach.Biochem Genet. 2024 Apr 30. doi: 10.1007/s10528-024-10790-w. Online ahead of print. Biochem Genet. 2024. PMID: 38689186
-
Targeted protein degradation: from mechanisms to clinic.Nat Rev Mol Cell Biol. 2024 Apr 29. doi: 10.1038/s41580-024-00729-9. Online ahead of print. Nat Rev Mol Cell Biol. 2024. PMID: 38684868 Review.
-
Caenorhabditis elegans as an In Vivo Model Organism to Elucidate Teratogenic Effects.Methods Mol Biol. 2024;2753:283-306. doi: 10.1007/978-1-0716-3625-1_14. Methods Mol Biol. 2024. PMID: 38285345
-
Development Features on the Selection of Animal Models for Teratogenic Testing.Methods Mol Biol. 2024;2753:67-104. doi: 10.1007/978-1-0716-3625-1_3. Methods Mol Biol. 2024. PMID: 38285334
-
Thrombotic and Hemorrhagic Complications Following Left Ventricular Assist Device Placement: An Emphasis on Gastrointestinal Bleeding, Stroke, and Pump Thrombosis.Cureus. 2023 Dec 27;15(12):e51160. doi: 10.7759/cureus.51160. eCollection 2023 Dec. Cureus. 2023. PMID: 38283491 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources